Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target refers to the collective group of dietary macronutrients—lipids, proteins, and carbohydrates—present within the gastrointestinal lumen that require enzymatic breakdown for systemic absorption. In patients suffering from Exocrine Pancreatic Insufficiency (EPI), the pancreas fails to secrete adequate amounts of endogenous digestive enzymes, leading to significant malabsorption and malnutrition [Mayo Clinic, 2023]. Pancreatic Enzyme Replacement Therapy (PERT) addresses this by providing exogenous lipase, protease, and amylase that directly target these luminal substrates [StatPearls, 2023]. Lipase facilitates the hydrolysis of fats into monoglycerides and free fatty acids, while proteases and amylases break down proteins and complex starches into absorbable peptides and simple sugars, respectively [PubChem, 2024]. This therapeutic intervention is critical for managing conditions such as cystic fibrosis, chronic pancreatitis, and pancreatic cancer, as it restores digestive function and improves the patient's nutritional status [Cystic Fibrosis Foundation, 2023]. Effective management requires precise dosing based on the fat content of the substrates to prevent symptoms like steatorrhea and weight loss.
Exogenous pancreatic enzymes (lipase, protease, and amylase) act within the gastrointestinal lumen to catalyze the hydrolysis of dietary fats into fatty acids and glycerol, proteins into peptides and amino acids, and carbohydrates into simple sugars, thereby facilitating their absorption [StatPearls, 2023; PubChem, 2024].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary substrates (Lipids, Proteins, and Carbohydrates).